研究炎症性细胞因子与COVID-19疾病的相关性
Nuha A Alkhattabi1, Hajer M Alharbi1, Mohammad A Basabrain2
1Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
细胞因子风暴标记物,包括互乐-6 (IL-6),瘤缩因子-α (TNF-α) 和干扰素马诱导蛋白10 (IP-10),在严重的COVID-19中升高. 疫苗似乎通过减少这些炎症标志物来减轻疾病的严重程度.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 病理学 病理学 病理学
背景情况:
- 细胞因子风暴,一种极端的免疫反应,与严重的COVID-19有关.
- 关键的炎症标志物如IL-6,TNF-α和IP-10是疾病严重程度的潜在指标.
研究的目的:
- 测量IL-6,TNF-α和IP-10的血清水平在患有轻度,重度和预先接种 (一剂量) COVID-19 的患者中.
- 评估这些细胞因子在COVID-19病变发生过程中的临床意义.
- 评估疫苗对这些炎症标志物的影响.
主要方法:
- 从72名参与者收集血清样本:18名健康对照组,18名轻度COVID-19,18名严重COVID-19和18名预先接种疫苗 (一剂量) 的COVID-19患者.
- 进行了IL-6,TNF-α和IP-10血清水平的量化.
主要成果:
- 与轻度和预先接种疫苗的组相比,严重的COVID-19患者的IL-6,TNF-α和IP-10循环水平显著更高.
- 轻度和预先接种疫苗的人群中的IL-6水平相对于重度组的IL-6水平明显较低.
- 这些细胞因子的水平升高与COVID-19严重程度的增加有关.
结论:
- IL-6,TNF-α和IP-10与COVID-19的致病性密切相关.
- 接种COVID-19疫苗,即使是一剂,也可以通过调节这些细胞因子反应来帮助减少疾病的严重程度.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
06:29Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
相关概念视频
The JAK-STAT Signaling Pathway
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
